Is NCT07213531 recruiting in New York, NY?

Yes, NCT07213531 is currently recruiting participants at its New York, NY location. This heart valve disease clinical trial is actively enrolling qualified participants.

How do I join the heart valve disease clinical trial in New York?

To join this clinical trial in New York, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this New York clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

New York, NYNCT07213531Now EnrollingIRB Ready

Heart Valve Disease Clinical Trial in New York, NY

Access cutting-edge heart valve disease treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Expert Care in New York

Access heart valve disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related heart valve disease treatment provided free

Apply for This New York Location

Check if you qualify for this heart valve disease clinical trial in New York, NY

Why Participate?

No-Cost Study Care
Local to New York
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

1Submit this form
2Phone screening
3Visit New York site if eligible
4Begin participation

About This Heart Valve Disease Study in New York

This non-interventional study aims to use artificial intelligence to improve the prediction of transcatheter heart valve interventions and optimize patient outcomes. It is based on the analysis of retrospective data from various specialized centers worldwide.

Sponsor: Montreal Heart Institute

Who Can Participate

Inclusion Criteria

Patients who have reached the age of legal majority under local laws.

For TAVI group: All patients who have had TAVI with a third generation transcatheter heart valve (THV), with an available pre-procedural optimal quality CT scan as defined by an ECG- gating CT with:

five to ten image volumes at cardiac phases from 5% to 95% R-R

625 mm slice thickness

625 mm spacing between slices

88 mm in-plane pixel spacing

For TMVI group: Patients who have had a TMVI with a dedicated device and screen failures, with an available optimal quality CT scan.

For TTVI group: Patients who have had a TTVI with a dedicated device and screen failures, with an available optimal quality CT scan.

For M-TEER: All patient who have had a M-TEER with 1) G4 or newer iteration of MitraClip or 2) G2 or newer iteration of Pascal, with available pre-procedural TEE videos images from one of two vendors: Phillips or GE, with clear identifiable views of the Mitral valve, frame per second equal or higher than 40 frames per second, acceptable 3D reconstructions.

For T-TEER: All patient who have had a T-TEER with G4 or newer iteration of TriClip or 2) G2 or newer iteration of Pascal, with available pre-procedural TEE videos images from one of two vendors: Phillips or GE, with clear identifiable views of the Tricuspid valve, frame per second equal or higher than 40 frames per second, acceptable transgastric image with acceptable 3D reconstructions.

Exclusion Criteria

For TAVI group: Valve-in-valve procedures

For TMVI group: Valve-in-valve and valve-in-ring procedures

For TTVI: Valve-in-valve and valve-in-ring procedures

For M-TEER: G3 or older MitraClip, G1 Pascal

For T-TEER: G3 Triclip, G1 Pascal

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT07213531) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Heart Valve Disease Treatment Options in New York, NY

If you're searching for heart valve disease treatment options in New York, NY, this clinical trial (NCT07213531) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart valve disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all heart valve disease clinical trials near you to find additional studies recruiting in your area.

More Valvular Heart Disease Trials in New York, NY

See all valvular heart disease clinical trials recruiting in New York — not just this study.

Browse Valvular Heart Disease Trials in New York →

Browse More Trials by Condition

Valvular Heart Disease Trials Ankylosing Spondylitis Trials All Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY